Multiplicity in randomised trials II: subgroup and interim analyses (Q34417512)

2 August 2017

title

Multiplicity in randomised trials II: subgroup and interim analyses (English)

1 reference

2 August 2017

David A Grimes

1 reference

2 August 2017

Kenneth F Schulz

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 May 2005

1 reference

2 August 2017

1 reference

2 August 2017

volume

365

1 reference

2 August 2017

issue

9471

1 reference

2 August 2017

page(s)

1657-1661

1 reference

Multiplicity in randomised trials I: endpoints and treatments.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

From star signs to trial guidelines.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Interaction revisited: the difference between two estimates

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Subgroup analysis and other (mis)uses of baseline data in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

What's wrong with Bonferroni adjustments

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Prevention of preterm birth in high-risk patients: the role of education and provider contact versus home uterine monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

When to stop a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Interim analyses in randomized clinical trials: ramifications and guidelines for practitioners.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

A Multiple Testing Procedure for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Sequential stopping rules in clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Systematic qualitative review of the literature on data monitoring committees for randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Reported use of data monitoring committees in the main published reports of randomized controlled trials: a cross-sectional study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Sample size calculations in randomised trials: mandatory and mystical

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Interim analysis: the alpha spending function approach.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Refining clinical diagnosis with likelihood ratios

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Applying Bayesian ideas in drug development and clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

The what, why and how of Bayesian clinical trials monitoring.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

The CHART trials: Bayesian design and monitoring in practice. CHART Steering Committee.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

Monitoring of large randomised clinical trials: a new approach with Bayesian methods

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2805%2966516-6

7 January 2021

10.1016/S0140-6736(05)66516-6

Identifiers

DOI

1 reference

2 August 2017

1 reference